Literature DB >> 7427172

Diuretic resistance: reduced bioavailability and effect of oral frusemide.

B O Odlind, B Beermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7427172      PMCID： PMC1601905          DOI： 10.1136/bmj.280.6231.1577

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Cyclical edema.

Authors:  G W THORN
Journal:  Am J Med       Date:  1957-10       Impact factor: 4.965

2.  Elimination of furosemide in healthy subjects and in those with renal failure.

Authors:  B Beermann; E Dalén; B Lindström
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

3.  Treatment of diuretic-resistant fluid retention with ultrafiltration.

Authors:  H Asaba; J Bergström; P Fürst; S Shaldon; S Wiklund
Journal:  Acta Med Scand       Date:  1978

4.  Pharmacokinetics/pharmacodynamics of furosemide in man: a review.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-02
  4 in total
  8 in total

Review 1.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 2.  Pharmacokinetics of loop diuretics in congestive heart failure.

Authors:  D C Brater
Journal:  Br Heart J       Date:  1994-08

3.  The influence of ascites on the pharmacokinetics of piretanide in cirrhotic patients.

Authors:  A N Shepherd; I A Bouchier
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Diuretic Resistance.

Authors:  Ewout J Hoorn; David H Ellison
Journal:  Am J Kidney Dis       Date:  2016-11-01       Impact factor: 8.860

5.  Absorption of high dose furosemide (frusemide) in congestive heart failure.

Authors:  J J Van Meyel; P G Gerlag; P Smits; F G Russel; Y Tan; C A Van Ginneken; F W Gribnau
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

Review 6.  Pharmacokinetic changes in patients with oedema.

Authors:  B Vrhovac; N Sarapa; I Bakran; M Huic; V Macolic-Sarinic; I Francetic; A Wolf-Coporda; F Plavsic
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

7.  Bioavailability of bumetanide in grossly oedematous patients.

Authors:  G R Bailie; A Grennan; S Waldek
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 8.  Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.

Authors:  Sanjana Gupta; Ruth J Pepper; Neil Ashman; Stephen B Walsh
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.